SCHEMBL5377476

SCHEMBL5377476

CCCCc1cc(-c2ccc(N)c(CCCC)c2)ccc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.48
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HSD17B10 Q99714 3/20 0.42
MAPK1 P28482 2/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TLR8 Q9NR97 2/20 0.42
CYP3A4 P08684 5/20 0.41
TSHR P16473 5/20 0.41
TDP1 Q9NUW8 4/20 0.41
TYR P14679 2/20 0.41
HRH2 P25021 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
ALOX15 P16050 2/20 0.37
TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10424535 0.94 TLR8 (0.44) SKP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL8076064 0.93 SKP2 (0.43) SKP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7876994 0.91 TLR8 (0.44) SKP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL360103 0.87 ALDH1A1 (0.40) SKP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL5380955 0.87 ALDH1A1 (0.45) SKP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL11117161 0.86 MEN1 (0.42) SKP2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL30227228 0.83 SKP2 (0.48) SKP2ALDH1A1MEN1KMT2AMAPT
SCHEMBL39005 0.83 SKP2 (0.48) SKP2ALDH1A1MEN1KMT2AMAPT
SCHEMBL4455067 0.82 SKP2 (0.52) SKP2ALDH1A1HSD17B10MAPK1MAPT
SCHEMBL8375841 0.82 SKP2 (0.67) SKP2ALDH1A1HSD17B10MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202359-B2 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2007-04-10 US disclosed
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2005-04-21 US disclosed
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2004-04-08 US disclosed
EP-0823459-B1 Disazo pigment composition and printing ink DAINIPPON INK & CHEMICALS (JP) 2002-04-17 EP disclosed
US-5803962-A Disazo pigment composition and printing ink DAINIPPON INK AND CHEMICALS, INC. (JP) 1998-09-08 US disclosed
EP-0823459-A2 Disazo pigment composition and printing ink DAINIPPON INK AND CHEMICALS, INC. (JP) 1998-02-11 EP disclosed
US-5493011-A PIGMENTING HIGH MOLECULAR WEIGHT NATURAL OR SYNTHETIC ORGANIC MATERIALS HOECHST AG (DE) 1996-02-20 US disclosed
EP-0518909-B1 WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE HOECHST AG (DE) 1994-05-25 EP disclosed
EP-0518909-A1 WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE. HOECHST AG (DE) 1992-12-23 EP disclosed
WO-1991013941-A1 WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE HOECHST AKTIENGESELLSCHAFT (DE) 1991-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 SKP2 2214/4885ALDH1A1 81/4885MEN1 3378/4885
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 SKP2 1761/4885ALDH1A1 116/4885MEN1 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.